News
Media
Conferences
Publications
Events
CME/CE
Resources
Career Center
Subscribe

Your AI-Trained Oncology Knowledge Connection!

Gilles Freyer

Articles by Gilles Freyer

19 Efficacy, Safety, and Quality of Life With Ribociclib + Endocrine Therapy in Elderly Patients With HR+/HER2– Advanced Breast Cancer Across the MONALEESA-2, -3, and -7 Trials

19 Efficacy, Safety, and Quality of Life With Ribociclib + Endocrine Therapy in Elderly Patients With HR+/HER2– Advanced Breast Cancer Across the MONALEESA-2, -3, and -7 Trials

ByLowell Hart,Seock-Ah Im,Sara M. Tolaney, MD, MPH,Mario Campone,Timothy Pluard,Berta Sousa,Gilles Freyer,Thomas Decker,Kevin Kalinsky, MD, MS,Astrid Thuerigen,Melissa Gao,Huilin Hu,Sherko Kümmel

August 9th 2024

Latest Updated Articles

Trending on CancerNetwork

Daratumumab Combo Yields Significantly Higher MRD Negativity in Multiple Myeloma

FDA Approves Subcutaneous Mosunetuzumab in R/R Follicular Lymphoma

FDA Grants BTD to T-DXd in HER2+ BC With Residual Invasive Disease Post NAT

JSKN003 Earns FDA Breakthrough Therapy Designation for HER2-Expressing PROC

Lu 177 Plus Immunotherapy Displays Responses in Prostate Cancer